|
COG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.643600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.096500E-03 |
| Normal-vs-Stage2 |
9.848800E-01 |
| Normal-vs-Stage3 |
2.003300E-03 |
| Normal-vs-Stage4 |
2.535600E-03 |
| Stage1-vs-Stage2 |
4.895900E-02 |
| Stage1-vs-Stage3 |
2.202600E-01 |
| Stage1-vs-Stage4 |
2.809000E-01 |
| Stage2-vs-Stage3 |
6.898900E-03 |
| Stage2-vs-Stage4 |
1.634430E-02 |
| Stage3-vs-Stage4 |
9.514000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.339200E-03 |
| Normal-vs-AfricanAmerican |
2.929600E-01 |
| Normal-vs-Asian |
6.555800E-02 |
| Caucasian-vs-AfricanAmerican |
4.540600E-01 |
| Caucasian-vs-Asian |
7.105600E-01 |
| AfricanAmerican-vs-Asian |
7.046000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.245800E-02 |
| Normal-vs-Female |
8.163500E-03 |
| Male-vs-Female |
6.325600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.441500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.565900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.856130E-02 |
| Normal-vs-Age(81-100Yrs) |
3.205900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.820400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.226200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.169200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.139800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.584600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.152000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.046520E-04 |
| Classical-VS-Follicular |
4.242600E-01 |
| Classical-VS-Other |
8.953000E-01 |
| Classical-VS-Normal |
1.982330E-02 |
| Tall-VS-Follicular |
2.588000E-04 |
| Tall-VS-Other |
2.192600E-01 |
| Tall-VS-Normal |
2.38040000000161E-06 |
| Follicular-VS-Other |
8.834800E-01 |
| Follicular-VS-Normal |
2.654000E-01 |
| Other-VS-Normal |
4.611000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.054100E-02 |
| Normal-vs-N1 |
2.383200E-04 |
| N0-vs-N1 |
1.007520E-02 |
|
|
